Non-Invasive Prenatal Testing (NIPT) Market Share, Size, Trends, Industry Analysis Report, By Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks); By Component (Consumables, Instruments, Software, Services); By Method; By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028

Report Scope

Non-Invasive Prenatal Testing Gestation Period Outlook (Revenue, USD Million, 2016 - 2028)

• 0-12 weeks
• 13-24 weeks
• 25-36 weeks

Non-Invasive Prenatal Testing Component Outlook (Revenue, USD Million, 2016 - 2028)

• Consumables
• Instruments
• Software
• Services

Non-Invasive Prenatal Testing Application Outlook (Revenue, USD Million, 2016 - 2028)

• Monosomy
• 三染色体细胞
• Microdeletion Syndrome
• Others

Non-Invasive Prenatal Testing Method Outlook (Revenue, USD Million, 2016 - 2028)

• Cell-Free DNA in Maternal Plasma Tests
• Ultrasound Detection
• Biochemical Screening Tests
• Others

Non-Invasive Prenatal Testing End-Use Outlook (Revenue, USD Million, 2016 - 2028)

• Diagnostic Centers
• Hospitals
• Clinics
• Others

Non-Invasive Prenatal Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • Non-Invasive Prenatal Testing Gestation Period Outlook
    • 0-12 weeks
    • 13-24 weeks
    • 25-36 weeks
  • Non-Invasive Prenatal Testing Component Outlook
    • Consumables
    • Instruments
    • Software
    • Services
  • Non-Invasive Prenatal Testing Application Outlook
    • Monosomy
    • 三染色体细胞
    • Microdeletion Syndrome
    • Others
  • Non-Invasive Prenatal Testing Method Outlook
    • Cell-Free DNA in Maternal Plasma Tests
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Others
  • Non-Invasive Prenatal Testing End-Use Outlook
    • Diagnostic Centers
    • Hospitals
    • Clinics
    • Others
• Europe
  • Non-Invasive Prenatal Testing Gestation Period Outlook
    • 0-12 weeks
    • 13-24 weeks
    • 25-36 weeks
  • Non-Invasive Prenatal Testing Component Outlook
    • Consumables
    • Instruments
    • Software
    • Services
  • Non-Invasive Prenatal Testing Application Outlook
    • Monosomy
    • 三染色体细胞
    • Microdeletion Syndrome
    • Others
  • Non-Invasive Prenatal Testing Method Outlook
    • Cell-Free DNA in Maternal Plasma Tests
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Others
  • Non-Invasive Prenatal Testing End-Use Outlook
    • Diagnostic Centers
    • Hospitals
    • Clinics
    • Others
• Asia Pacific
  • Non-Invasive Prenatal Testing Gestation Period Outlook
    • 0-12 weeks
    • 13-24 weeks
    • 25-36 weeks
  • Non-Invasive Prenatal Testing Component Outlook
    • Consumables
    • Instruments
    • Software
    • Services
  • Non-Invasive Prenatal Testing Application Outlook
    • Monosomy
    • 三染色体细胞
    • Microdeletion Syndrome
    • Others
  • Non-Invasive Prenatal Testing Method Outlook
    • Cell-Free DNA in Maternal Plasma Tests
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Others
  • Non-Invasive Prenatal Testing End-Use Outlook
    • Diagnostic Centers
    • Hospitals
    • Clinics
    • Others
• Latin America
  • Non-Invasive Prenatal Testing Gestation Period Outlook
    • 0-12 weeks
    • 13-24 weeks
    • 25-36 weeks
  • Non-Invasive Prenatal Testing Component Outlook
    • Consumables
    • Instruments
    • Software
    • Services
  • Non-Invasive Prenatal Testing Application Outlook
    • Monosomy
    • 三染色体细胞
    • Microdeletion Syndrome
    • Others
  • Non-Invasive Prenatal Testing Method Outlook
    • Cell-Free DNA in Maternal Plasma Tests
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Others
  • Non-Invasive Prenatal Testing End-Use Outlook
    • Diagnostic Centers
    • Hospitals
    • Clinics
    • Others
• Middle East & Africa
  • Non-Invasive Prenatal Testing Gestation Period Outlook
    • 0-12 weeks
    • 13-24 weeks
    • 25-36 weeks
  • Non-Invasive Prenatal Testing Component Outlook
    • Consumables
    • Instruments
    • Software
    • Services
  • Non-Invasive Prenatal Testing Application Outlook
    • Monosomy
    • 三染色体细胞
    • Microdeletion Syndrome
    • Others
  • Non-Invasive Prenatal Testing Method Outlook
    • Cell-Free DNA in Maternal Plasma Tests
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Others
  • Non-Invasive Prenatal Testing End-Use Outlook
    • Diagnostic Centers
    • Hospitals
    • Clinics
    • Others

Qualitative Analysis

• Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
• Competitive landscape
  • Overview
  • Financials
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecasts from 2016 - 2028
• Market revenue estimates for gestation period up to 2028
• Market revenue estimates for component up to 2028
• Market revenue estimates for application up to 2028
• Market revenue estimates for method up to 2028
• Market revenue estimates for end-use up to 2028
• Regional market size and forecast up to 2028
• Company financials